Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes.
暂无分享,去创建一个
Paul A Lyons | John A Todd | J. Todd | G. Ghandour | P. Lyons | L. Wicker | R. Glynne | L. Peterson | Richard J Glynne | I. Eaves | Linda S Wicker | Ghassan Ghandour | Iain A Eaves | Laurence B Peterson
[1] G. Hedlund,et al. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. , 1998, Journal of immunology.
[2] N. Sarvetnick,et al. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. , 1999, Journal of immunology.
[3] John A Todd,et al. Genetic Analysis of Autoimmune Disease , 1996, Cell.
[4] Kenneth G. C. Smith,et al. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII , 2000, Current Biology.
[5] U. Wahn,et al. Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1 , 2000, The Journal of Immunology.
[6] L. Wicker,et al. Genetic Control of Diabetes and Insulitis in the Nonobese Diabetic Mouse: Analysis of the NOD. H-2b and B10. H-2nod Strains , 1993 .
[7] J. Warrington,et al. A high-density probe array sample preparation method using 10- to 100-fold fewer cells , 1999, Nature Biotechnology.
[8] N. Risch,et al. Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.
[9] A. Cerami,et al. Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78. , 1991, Journal of immunology.
[10] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[11] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[12] H E Wichmann,et al. A mathematical model of erythropoiesis in mice and rats. Part 4: Differences between bone marrow and spleen , 1990, Cell and tissue kinetics.
[13] M. Atkinson,et al. The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.
[14] M. Loeffler,et al. A mathematical model of erythropoiesis in mice and rats Part 3: Suppressed erythropoiesis , 1989, Cell and tissue kinetics.
[15] Pierre Baldi,et al. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes , 2001, Bioinform..
[16] D. Botstein,et al. Two yeast forkhead genes regulate the cell cycle and pseudohyphal growth , 2000, Nature.
[17] James Scott,et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.
[18] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[19] J. Todd,et al. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. , 2000, Genome research.
[20] A. Woodcock,et al. The −403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma , 2000, Genes and Immunity.
[21] J. Todd,et al. From genome to aetiology in a multifactorial disease, type 1 diabetes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] W. Fridman,et al. Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. , 1996, Journal of immunology.
[23] N. Schork,et al. Crosses of NOD Mice With the Related NON Strain: A Polygenic Model for IDDM , 1995, Diabetes.
[24] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[25] D. Pipeleers,et al. Pancreatic beta cells in insulin-dependent diabetes. , 1992, Diabetes/metabolism reviews.
[26] K. Laupland,et al. Genetic Linkage of Thymic T-Cell Proliferative Unresponsiveness to Mouse Chromosome 11 in NOD Mice: A Possible Role for Chemokine Genes , 1995, Diabetes.
[27] R. Doerge,et al. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. , 1999, Journal of immunology.
[28] G. Dorn,et al. Genetic Causes of Cardiac Hypertrophy Divergent Transcriptional Responses to Independent , 2022 .
[29] Soumitra Ghosh,et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.
[30] S. Dudoit,et al. Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. , 2000, Genome research.
[31] V. Appay,et al. RANTES: a versatile and controversial chemokine. , 2001, Trends in immunology.
[32] J. Todd,et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. , 2000, Immunity.
[33] S. P. Fodor,et al. High density synthetic oligonucleotide arrays , 1999, Nature Genetics.
[34] P. Lyons,et al. Localising quantitative trait loci in the NOD mouse model of type 1 diabetes. , 1999, Current directions in autoimmunity.
[35] J. Todd,et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. , 1998, Journal of immunology.
[36] G. Ghandour,et al. Genomic-scale gene expression analysis of lymphocyte growth, tolerance and malignancy. , 2000, Current opinion in immunology.
[37] W. Philbrick,et al. A recombination event in the 5′ flanking region of the Ly‐6C gene correlates with impaired expression in the NOD, NZB and ST strains of mice. , 1990, The EMBO journal.
[38] John W. Tukey,et al. Exploratory Data Analysis. , 1979 .
[39] J. Todd,et al. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. , 2000, Diabetes.
[40] A. Baxter,et al. Hemolytic anemia in non‐obese diabetic mice , 1991, European journal of immunology.
[41] W. Ollier,et al. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. , 2000, Clinical and experimental rheumatology.
[42] J. Todd,et al. Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.
[43] A. Baxter,et al. Linkage Analysis of Systemic Lupus Erythematosus Induced in Diabetes-Prone Nonobese Diabetic Mice by Mycobacterium bovis1 , 2000, The Journal of Immunology.
[44] E. Neilson,et al. Cloning, genomic organization, and chromosomal localization of the Scya5 gene encoding the murine chemokine RANTES. , 1994, Journal of immunology.
[45] J. Westwick,et al. Chemokines: understanding their role in T-lymphocyte biology. , 1998, The Biochemical journal.
[46] N. Risch,et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus , 1998, Nature Genetics.
[47] P. Avner,et al. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. , 2001, Genomics.
[48] G. Peltz,et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma , 2000, Nature Immunology.
[49] Amanda J. Wilson,et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom , 1998, Nature Genetics.
[50] J. Todd,et al. Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene , 1997, Diabetes.